2015 Seminar Schedule

Date Speaker Title Host
March 20th at HMRI Dr Nikola Bowden, HMRI, University of Newcastle Targeting DNA repair to overcome chemoresistance in melanoma and ovarian cancer. Kathryn Skelding
April 1st (HMRI, Wednesday 4.30 pm) Special Seminar: Dr Alex Swarbrick , Kinghorn Cancer Center, Garvan Institute, Sydney Hedgehog signalling as a novel therapeutic target for triple negative breast cancer. Matt Dun
April 24th Dr Annemiek Beverdam, University of New South Wales YAP is molecular switch in epidermal stem cell proliferation and differentiation. Pradeep Tanwar
May 8th Dr Jessica Holien, St Vincent's Institute, Melbourne Designing Protein-Protein Inhibitors. Kathryn Skelding
May 15th Dr. Thomas Fath, School of Medical Sciences, Faculty of Medicine, UNSW, Sydney Diversity and Function of the Neuronal Actin Cytoskeleton – Implications in Development and Disease. Estelle Sontag
May 22nd Crystal Naudin, PhD student, School of Biomedical Sciences and Pharmacy, University of Newcastle The Tetraspanin CD151's Role in the Kidney and Mapping of Genetic Modifiers of Glomerular Disease. Kathryn Skelding
June 5th Dr Christine Napier, Children's Medical Research Institute, Sydney Chromosome end protection and the road to cancer. Kathryn Skelding
June 12th Prof Ross Vlahos, RMIT University Targeting novel oxidant-dependent mechanisms to treat acute and chronic lung diseases. Darryl Knight
June 19th Prof Russ Chess-Williams, Faculty of Health Sciences & Medicine, Bond University Anti-cancer effects of alpha1-adrenoceptor antagonists. Dirk Van Helden
June 26th Dr Sarah Gordon, Florey Institute of Neuroscience and Mental Health, University of Melbourne Synaptic vesicle recycling in health and disease. Phil Dickson
July 3rd Assistant Professor James Elliott, Northwestern University, Chicago Demystifying the Whiplash Condition - from Protons to Prognosis. Phil Bolton
July 10th Dr Jill Larsen, QIMR Berghofer Medical Research Institute Identifying 'cooperative' mutations in non-small cell lung carcinoma using immortalised human bronchial epithelial cells. Kathryn Skelding
July 17th Dr Nathan Bartlett, HMRI, University of Newcastle The airway epithelium-immune interface and virus-induced asthma. Kathryn Skelding
July 31st Prof Allison Cowin, University of South Australia Cytoskeletal regulation of wound healing and inflammation. Phil Hansbro
August 7th Emeritus Prof Saxon White, School of Biomedical Sciences and Pharmacy, University of Newcastle The New Physiology of Stress: Claude Bernard, Walter Cannon and Tony Abbott. Kathryn Skelding
August 14th Prof Robert Medcalf, Fibrinolysis and Gene Regulation Laboratory, Monash University The fibrinolytic (plasminogen activating) system: for blood clots or for the CNS? Neil Spratt
August 21st Dr Irfan Beig and Dr Ee Cheng Khor - Scientific Liasion Sigma-Aldrich

Latest Trend in Genome Editing by CRISPR/Cas 9.

Kathryn Skelding
August 28th Danielle Bond and Jay Pundavela, PhD Students, School of Biomedical Sciences and Pharmacy, University of Newcastle Danielle:"Post-transcriptional Regulation of Tetraspanins CD151 & CD9 by miRNAs in Breast and Prostate Cancers" and Jay:"ProNGF / NGF and nerve infiltration in prostate and breast cancer". Kathryn Skelding
September 11th A/Prof Kuldip Sidhu, UNSW, Sydney Patient-derived stem cells - new paradigm in human medicine. Peter Howe
September 18th Dr Linda Rehaume, Diamantina Institute, University of Queensland Host immunogenetic background disrupts the relationship between microbiota and gut mucosa leading to spondyloarthritis and ileitis. Phil Hansbro
October 2nd Dr Daniel Beard and Dr Trisha Al Mazi, School of Biomedical Sciences and Pharmacy, University of Newcastle Daniel:"The double-edged sword of collateral blood flow in stroke: Presence of collaterals influences the development of intracranial pressure rise, and intracranial pressure rise reduces collateral blood flow" and Trisha"P53 responses to Fludarabine induced apoptosis in hematological malignancies". Damian McLeod and Vikki Verrills
October 9th Dr Nikki Verrills, School of Biomedical Sciences and Pharmacy, University of Newcastle Bottom Up and Top Down – complementary approaches in oncology research. Phil Dickson
October 16th Dr Snezana Kusljic, School of Health Sciences, University of Melbourne Polypharmacy, age-dependent physiological changes and risk of falls in older people. Karen Kerr
October 23rd Dr Laura Corbit, Brain and Mind Institute, University of Sydney Understanding the effects of diet on decision making and the neural circuits underlying behavioural control. Chris Dayas
October 30th Dr Yoichiro Otsuka, School of Medicine, Flinders University of South Australia Brain neural pathways mediating autonomic physiological response to stress. Eugene Nalivaiko
November 6th A/Prof Luke Henderson, University of Sydney Central Changes in Chronic Pain. Philip Bolton
November 20th Dr Mengna Chi, School of Biomedical Sciences and Pharmacy, University of Newcastle BAALC - A Novel Therapeutic Target for Controlling Cancer Cell Functions Kathryn Skelding
November 27th Dr Ashley Mansell, Hudson Institute Melbourne Inflammasomes: Friend or Foe? Phil Hansbro
December 4th Dr Dusan Matusica,Centre for Neuroscience,School of Medicine, Flinders University Modulation of Trk receptor signalling by an intracellular domain fragment of the p75 neurotrophin receptor. Hubert Hondermarck